Skip Nav Destination
Issues
1 February 2015
-
Cover Image
Cover Image
The cover shows NFκB translocation in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Immunocytochemistry staining shows NFκB (p65) translocation (red is nucleus; green is NFκB; and yellow is overlay [translocation]) in the nucleus of tumor-infiltrating lymphocytes expanded with IL-2 and an anti-4-1BB antibody. For details, see the article by Chacon and colleagues on page 611 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR 20th Anniversary Commentary
CCR Translations
Molecular Pathways
Special Report
Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology
Thomas H. Brandon; Maciej L. Goniewicz; Nasser H. Hanna; Dorothy K. Hatsukami; Roy S. Herbst; Jennifer A. Hobin; Jamie S. Ostroff; Peter G. Shields; Benjamin A. Toll; Courtney A. Tyne; Kasisomayajula Viswanath; Graham W. Warren
Review
Cancer Therapy: Clinical
Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans
Smita S. Chandran; Biman C. Paria; Abhishek K. Srivastava; Luke D. Rothermel; Daniel J. Stephens; Mark E. Dudley; Robert Somerville; John R. Wunderlich; Richard M. Sherry; James C. Yang; Steven A. Rosenberg; Udai S. Kammula
Phase II Clinical and Exploratory Biomarker Study of Dacomitinib in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
Han Sang Kim; Hyeong Ju Kwon; Inkyung Jung; Mi Ran Yun; Myung-Ju Ahn; Byung Woog Kang; Jong-Mu Sun; Sung Bae Kim; Dok-Hyun Yoon; Keon Uk Park; Se-Hoon Lee; Yoon Woo Koh; Se Hun Kim; Eun Chang Choi; Dong Hoe Koo; Jin Hee Sohn; Bomi Kim; Nak-Jung Kwon; Hwan Jung Yun; Min Goo Lee; Ji Hyun Lee; Tae-Min Kim; Hye Ryun Kim; Joo Hang Kim; Soonmyung Paik; Byoung Chul Cho
Author Choice
First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma
Jordi Rodon; Michael A. Carducci; Juan M Sepulveda-Sánchez; Analia Azaro; Emiliano Calvo; Joan Seoane; Irene Braña; Elisabet Sicart; Ivelina Gueorguieva; Ann L. Cleverly; N. Sokalingum Pillay; Durisala Desaiah; Shawn T. Estrem; Luis Paz-Ares; Matthias Holdhoff; Jaishri Blakeley; Michael M. Lahn; Jose Baselga
Personalized Medicine and Imaging
Author Choice
The High-Dose Aldesleukin “Select” Trial: A Trial to Prospectively Validate Predictive Models of Response to Treatment in Patients with Metastatic Renal Cell Carcinoma
David F. McDermott; Su-Chun Cheng; Sabina Signoretti; Kim A. Margolin; Joseph I. Clark; Jeffrey A. Sosman; Janice P. Dutcher; Theodore F. Logan; Brendan D. Curti; Marc S. Ernstoff; Leonard Appleman; Michael K.K. Wong; Nikhil I. Khushalani; Leslie Oleksowicz; Ulka N. Vaishampayan; James W. Mier; David J. Panka; Rupal S. Bhatt; Alexandra S. Bailey; Bradley C. Leibovich; Eugene D. Kwon; Fairooz F. Kabbinavar; Arie S. Belldegrun; Robert A. Figlin; Allan J. Pantuck; Meredith M. Regan; Michael B. Atkins
Author Choice
High HER2 Expression Correlates with Response to the Combination of Lapatinib and Trastuzumab
Maurizio Scaltriti; Paolo Nuciforo; Ian Bradbury; Jeff Sperinde; Dominique Agbor-Tarh; Christine Campbell; Ahmed Chenna; John Winslow; Violeta Serra; Josep Lluis Parra; Ludmila Prudkin; José Jimenez; Claudia Aura; Nadia Harbeck; Lajos Pusztai; Catherine Ellis; Holger Eidtmann; Joaquin Arribas; Javier Cortes; Evandro de Azambuja; Martine Piccart; José Baselga
Optical Mammography Using Diffuse Optical Spectroscopy for Monitoring Tumor Response to Neoadjuvant Chemotherapy in Women with Locally Advanced Breast Cancer
Boudewijn E. Schaafsma; Martijn van de Giessen; Ayoub Charehbili; Vincent T.H.B.M. Smit; Judith R. Kroep; Boudewijn P.F. Lelieveldt; Gerrit-Jan Liefers; Alan Chan; Clemens W.G.M. Löwik; Jouke Dijkstra; Cornelis J.H. van de Velde; Martin N.J.M. Wasser; Alexander L. Vahrmeijer
A Five-Gene Hedgehog Signature Developed as a Patient Preselection Tool for Hedgehog Inhibitor Therapy in Medulloblastoma
Yaping Shou; Douglas M. Robinson; Dereck D. Amakye; Kristine L. Rose; Yoon-Jae Cho; Keith L. Ligon; Thad Sharp; Asifa S. Haider; Raj Bandaru; Yuichi Ando; Birgit Geoerger; François Doz; David M. Ashley; Darren R. Hargrave; Michela Casanova; Hussein A. Tawbi; Jordi Rodon; Anne L. Thomas; Alain C. Mita; Tobey J. MacDonald; Mark W. Kieran
Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer
Justin Bottsford-Miller; Hyun-Jin Choi; Heather J. Dalton; Rebecca L. Stone; Min Soon Cho; Monika Haemmerle; Alpa M. Nick; Sunila Pradeep; Behrouz Zand; Rebecca A. Previs; Chad V. Pecot; Erin King Crane; Wei Hu; Susan K. Lutgendorf; Vahid Afshar-Kharghan; Anil K. Sood
Cancer Therapy: Preclinical
Author Choice
Manipulating the Tumor Microenvironment Ex Vivo for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
Jessica Ann Chacon; Amod A. Sarnaik; Jie Qing Chen; Caitlin Creasy; Charuta Kale; John Robinson; Jeffrey Weber; Patrick Hwu; Shari Pilon-Thomas; Laszlo Radvanyi
Biology of Human Tumors
Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection
Darragh P. O'Brien; Neomal S. Sandanayake; Claire Jenkinson; Aleksandra Gentry-Maharaj; Sophia Apostolidou; Evangelia-Ourania Fourkala; Stephane Camuzeaux; Oleg Blyuss; Richard Gunu; Anne Dawnay; Alexey Zaikin; Ross C. Smith; Ian J. Jacobs; Usha Menon; Eithne Costello; Stephen P. Pereira; John F. Timms
Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas
Tanguy Y. Seiwert; Zhixiang Zuo; Michaela K. Keck; Arun Khattri; Chandra S. Pedamallu; Thomas Stricker; Christopher Brown; Trevor J. Pugh; Petar Stojanov; Juok Cho; Michael S. Lawrence; Gad Getz; Johannes Brägelmann; Rebecca DeBoer; Ralph R. Weichselbaum; Alexander Langerman; Louis Portugal; Elizabeth Blair; Kerstin Stenson; Mark W. Lingen; Ezra E.W. Cohen; Everett E. Vokes; Kevin P. White; Peter S. Hammerman
Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation
Tatsuya Yoshida; Genichiro Ishii; Koichi Goto; Shinya Neri; Hiroko Hashimoto; Kiyotaka Yoh; Seiji Niho; Shigeki Umemura; Shingo Matsumoto; Hironobu Ohmatsu; Shinsuke Iida; Akio Niimi; Kanji Nagai; Yuichiro Ohe; Atsushi Ochiai
Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer
Francisco J. Candido-dos-Reis; for EMBRACE; Honglin Song; for EMBRACE; Ellen L. Goode; for EMBRACE; Julie M. Cunningham; for EMBRACE; Brooke L. Fridley; for EMBRACE; Melissa C. Larson; for EMBRACE; Kathryn Alsop; for EMBRACE; Ed Dicks; for EMBRACE; Patricia Harrington; for EMBRACE; Susan J. Ramus; for EMBRACE; Anna de Fazio; for EMBRACE; Gillian Mitchell; for EMBRACE; Sian Fereday; for EMBRACE; Kelly L. Bolton; for EMBRACE; Charlie Gourley; for EMBRACE; Caroline Michie; for EMBRACE; Beth Karlan; for EMBRACE; Jenny Lester; for EMBRACE; Christine Walsh; for EMBRACE; Ilana Cass; for EMBRACE; Håkan Olsson; for EMBRACE; Martin Gore; for EMBRACE; Javier J. Benitez; for EMBRACE; Maria J. Garcia; for EMBRACE; Irene Andrulis; for EMBRACE; Anna Marie Mulligan; for EMBRACE; Gord Glendon; for EMBRACE; Ignacio Blanco; for EMBRACE; Conxi Lazaro; for EMBRACE; Alice S. Whittemore; for EMBRACE; Valerie McGuire; for EMBRACE; Weiva Sieh; for EMBRACE; Marco Montagna; for EMBRACE; Elisa Alducci; for EMBRACE; Siegal Sadetzki; for EMBRACE; Angela Chetrit; for EMBRACE; Ava Kwong; for EMBRACE; Susanne K. Kjaer; for EMBRACE; Allan Jensen; for EMBRACE; Estrid Høgdall; for EMBRACE; Susan Neuhausen; for EMBRACE; Robert Nussbaum; for EMBRACE; Mary Daly; for EMBRACE; Mark H. Greene; for EMBRACE; Phuong L. Mai; for EMBRACE; Jennifer T. Loud; for EMBRACE; Kirsten Moysich; for EMBRACE; Amanda E. Toland; for EMBRACE; Diether Lambrechts; for EMBRACE; Steve Ellis; for EMBRACE; Debra Frost; for EMBRACE; James D. Brenton; for EMBRACE; Marc Tischkowitz; for EMBRACE; Douglas F. Easton; for EMBRACE; Antonis Antoniou; for EMBRACE; Georgia Chenevix-Trench; for EMBRACE; Simon A. Gayther; for EMBRACE; David Bowtell; for EMBRACE; Paul D.P. Pharoah; for EMBRACE
Letters to the Editor
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.